Insider · CIK 0001377759
Bermingham Nessan
Reports to the SEC for 3 companies · CAMBRIDGE, MA
Transactions
27
Companies
3
Filings
12
CIK
0001377759
Forms 4 and 5
Insider transactions
| Date | Company | Value |
|---|---|---|
| 2026-06-10 | KRROKorro Bio, Inc. · Stock Option (Right to Buy)A Award | — |
| 2025-06-11 | KRROKorro Bio, Inc. · Stock Option (Right to Buy)A Award | — |
| 2024-06-11 | KRROKorro Bio, Inc. · Stock Option (Right to Buy)A Award | — |
| 2023-11-03 | KRROKorro Bio, Inc.A Award | — |
| 2023-11-03 | KRROKorro Bio, Inc. · Stock Option (Right to Buy)A Award | — |
| 2023-11-03 | KRROKorro Bio, Inc. · Stock Option (Right to Buy)A Award | — |
| 2023-03-08 | F-star Therapeutics, Inc.Stock Option (right to buy)D Disposition to Issuer | — |
| 2023-03-08 | F-star Therapeutics, Inc.Stock Option (right to buy)D Disposition to Issuer | — |
| 2023-03-08 | F-star Therapeutics, Inc.D Disposition to Issuer | −$45.1K |
| 2023-03-08 | F-star Therapeutics, Inc.U Disposition from Tender | −$695K |
| 2023-03-08 | F-star Therapeutics, Inc.Stock Option (right to buy)D Disposition to Issuer | — |
| 2022-06-17 | F-star Therapeutics, Inc.Stock OptionA Award | — |
| 2021-06-04 | F-star Therapeutics, Inc.Stock OptionA Award | — |
| 2021-02-01 | F-star Therapeutics, Inc.A Award | — |
| 2020-11-20 | F-star Therapeutics, Inc.Restricted Stock UnitsA Award | — |
| 2020-11-20 | F-star Therapeutics, Inc.A Award | — |
| 2020-11-20 | F-star Therapeutics, Inc.Stock Option (right to buy)A Award | — |
| 2017-12-12 | NTLAIntellia Therapeutics, Inc. · Stock Option (right to buy)A Award | — |
| 2017-12-08 | NTLAIntellia Therapeutics, Inc.S Sale | −$1.96M |
| 2017-12-07 | NTLAIntellia Therapeutics, Inc.S Sale | −$2.18M |
| 2017-12-07 | NTLAIntellia Therapeutics, Inc.S Sale | −$591K |
| 2017-12-06 | NTLAIntellia Therapeutics, Inc.S Sale | −$2.01M |
| 2017-12-06 | NTLAIntellia Therapeutics, Inc.S Sale | −$260K |
| 2017-06-01 | NTLAIntellia Therapeutics, Inc.A Award | +$100K |
| 2017-01-06 | NTLAIntellia Therapeutics, Inc. · Stock Option (right to buy)A Award | — |
| 2016-05-11 | NTLAIntellia Therapeutics, Inc.C Conversion | — |
| 2016-05-11 | NTLAIntellia Therapeutics, Inc. · Founder StockC Conversion | — |
Recent filings
- 4Bermingham Nessan0001193125-26-268006SEC(opens sec.gov)
- 4Bermingham Nessan0000950170-25-085455SEC(opens sec.gov)
- 4Bermingham Nessan0000950170-24-072557SEC(opens sec.gov)
- 4Bermingham Nessan0000950170-23-060608SEC(opens sec.gov)
- 4Bermingham Nessan0000899243-23-007657SEC(opens sec.gov)
- 4Bermingham Nessan0001209191-22-038714SEC(opens sec.gov)
- 4/ABermingham Nessan0001209191-21-053233SEC(opens sec.gov)
- 4Bermingham Nessan0001209191-21-038563SEC(opens sec.gov)
- 4Bermingham Nessan0001209191-21-006741SEC(opens sec.gov)
- 4Bermingham Nessan0001209191-20-060342SEC(opens sec.gov)
- 4Bermingham Nessan0001209191-17-065659SEC(opens sec.gov)
- 4Bermingham Nessan0001209191-17-064786SEC(opens sec.gov)
Companies
Address
C/O KORRO BIO, INC. 60 FIRST STREET, 2ND FLOOR, SUITE 250
CAMBRIDGE, MA, 02141